Preferred Name |
dalbavancin |
|
Synonyms |
MDL-64397 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C469289 |
|
altLabel |
MDL-64397 Zeven VER-001 BI397 Dalvance VER001 MDL 64,397 BI-397 BI 397 A-A-1 antibiotic Xydalba |
|
cui |
C0911853 C5564769 C4722579 C4279629 C4733209 C3832636 C1172636 C0911854 |
|
Has mapping qualifier | ||
HM |
D017334/Q000031 |
|
II |
D000900 |
|
Inverse of RB |
0 808UI9MS5K |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
20021212 |
|
MeSH Frequency |
318 |
|
MMR |
20211213 |
|
notation |
C469289 |
|
PA |
D000900 |
|
PI |
*GLYCOPEPTIDES (2002-2005) |
|
prefLabel |
dalbavancin |
|
SC |
1 |
|
Scope Statement |
derivative of A-40926; interferes with peptidoglycan synthesis |
|
SRC |
Curr Opin Investig Drugs 2002 Feb;3(2):229-33 |
|
TERMUI |
T001115968 T406770 T528215 T001115965 T406768 T001115969 T001115970 T000874090 T001115967 T406769 T001115964 T000899754 |
|
TH |
NLM (2016) NLM (2002) NLM (2000) FDA SRS (2017) NLM (2015) USAN (19XX) INN (19XX) FDA SRS (2015) |
|
tui |
T109 T195 T116 T121 |
Create mapping